Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.

Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site now displays revision v3.5.0; revision v3.4.3 has been removed.SummaryDifference0.0%

- Check27 days agoChange Detected- Revision: v3.4.3 added; previous v3.4.2 removed. This update affects only the page's version label and does not alter study content or functionality.SummaryDifference0.0%

- Check55 days agoChange DetectedAdministrative updates: Revision: v3.4.2 is added and older notices (v3.4.1) are removed; these changes do not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedAdded a site-wide funding status notice directing users to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded UI elements: a Show glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label. Updated footer text to display 'No FEAR Act Data' and 'Revision: v3.4.0'.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.